ORBIMED ADVISORS LLC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Forte Biosciences, Inc. (FBRX)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: Forte Biosciences, Inc. Common Stock, par value $0.001 per share
Symbol: FBRX
Shares outstanding: 6.38M shares
Disclosed Ownership: 510K shares
Ownership: 8%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 04:22 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	8%	510K	0	510K	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	1.4%	90K	90K	0	/s/ Carl L. Gordon	Carl L. Gordon/Member